Search
中/EN
Contact/Message
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
Search
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
中/EN
Contact/Message
Innovate
Your current position:
Home
Innovate
International innovative drugs
NGENLA
NGENLA
departments:
儿科
drug:
注射液
Active:
SOMATROGON-GHLA
indication:
NGENLA是一种人类生长激素类似物,用于治疗因内源性生长激素分泌不足的3岁及以上的儿童患者。
Licensor:
PFIZER IRELAND PHARMACEUTICALS
Approved Country/Region:
美国
Approval time:
2023-06-27